FDA accepts Viatris drug application for fast-acting meloxicam pain treatment

Go back to FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
(NASDAQ: VTRS) Delayed: 16.48 +0.17 (1.04%)
Previous Close $16.31    52 Week High
Open $16.47    52 Week Low
Day High $16.63    P/E N/A 
Day Low $16.33    EPS
Volume 6,231,327